These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 12172403)
1. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Summerton CB; Longlands MG; Wiener K; Shreeve DR Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403 [TBL] [Abstract][Full Text] [Related]
2. Faecal calprotectin concentrations in gastrointestinal diseases. Wang S; Wang Z; Shi H; Heng L; Juan W; Yuan B; Wu X; Wang F J Int Med Res; 2013 Aug; 41(4):1357-61. PubMed ID: 23723365 [TBL] [Abstract][Full Text] [Related]
3. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563 [TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983 [TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964 [TBL] [Abstract][Full Text] [Related]
6. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593 [TBL] [Abstract][Full Text] [Related]
7. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure. Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305 [TBL] [Abstract][Full Text] [Related]
8. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms. Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083 [TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin in the diagnosis of inflammatory bowel disease. Burri E; Beglinger C Biochem Med (Zagreb); 2011; 21(3):245-53. PubMed ID: 22420238 [TBL] [Abstract][Full Text] [Related]
10. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Gisbert JP; McNicholl AG Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356 [TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796 [TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation. Gearry R; Barclay M; Florkowski C; George P; Walmsley T N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739 [No Abstract] [Full Text] [Related]
13. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186 [TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Kronborg O; Ugstad M; Fuglerud P; Johne B; Hardcastle J; Scholefield JH; Vellacott K; Moshakis V; Reynolds JR Gut; 2000 Jun; 46(6):795-800. PubMed ID: 10807890 [TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Aadland E; Fagerhol MK Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):823-5. PubMed ID: 12172400 [TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness. Burri E; Manz M; Schroeder P; Froehlich F; Rossi L; Beglinger C; Lehmann FS BMC Gastroenterol; 2014 Mar; 14():57. PubMed ID: 24679065 [TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings. Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733 [TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. van Rheenen PF; Van de Vijver E; Fidler V BMJ; 2010 Jul; 341():c3369. PubMed ID: 20634346 [TBL] [Abstract][Full Text] [Related]
20. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children. Sandhu K; Naik S; Ayling RM Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]